Target intelligence / Profile preview

MicroRNA 1914 (MIR1914)

Target
MIR1914
Molecular classification
MicroRNA, Non-coding RNA
01

Overview

MicroRNA 1914 (MIR1914) is a short, non-coding RNA molecule (20–24 nucleotides) belonging to the microRNA family and acts primarily by regulating gene expression at the post-transcriptional level[5]. It is transcribed as part of a primary transcript, subsequently processed by Drosha and Dicer enzymes to yield the mature miRNA, which is then loaded into the RNA-induced silencing complex (RISC). MIR1914 participates in mRNA silencing via partial base pairing, which typically results in translational repression or degradation of target mRNAs[5][2]. MIR1914 has been identified as differentially expressed in certain cancers: it distinguishes between gastric cancer subtypes (up- or down-regulated in signet-ring cell carcinoma vs. tubular adenocarcinoma)[1] and may contribute to chemoresistance in colorectal cancer[6]. More broadly, miRNAs including MIR1914 are implicated in cancer pathogenesis, cell cycle regulation, apoptosis, immune response, and may serve as disease biomarkers and potential future therapeutic targets[4][5].

Other names
hsa-mir-1914MIRN1914
02

Mechanism of action

miRNA-mediated gene silencing (inhibition of target mRNA translation or promotion of mRNA degradation)

03

Biological functions

Post-transcriptional gene regulationmRNA destabilizationTranslation inhibitionRNA silencing
04

Disease associations

Cancergastric cancer (signet-ring cell carcinoma)Colorectal cancerCommon wartCervix carcinoma
05

Safety considerations

No notable safety concerns or therapeutic challenges directly attributed to MIR1914General challenges with miRNA-based therapeutics may include off-target effects and delivery
06

Biomarkers

Potential biomarker for subtype differentiation in gastric cancerPotential biomarker for chemoresistance in colorectal cancer

Beyond the preview

Go deeper on MicroRNA 1914 (MIR1914).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 1914 (MIR1914).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call